Cargando…
A pilot phase II study of neoadjuvant triplet chemotherapy regimen in patients with locally advanced resectable colon cancer
OBJECTIVE: This study aims to investigate the feasibility, safety and efficacy of triplet regimen of neoadjuvant chemotherapy in patients with locally advanced resectable colon cancer. METHODS: Patients with clinical stage IIIb colon cancer received a perioperative triple chemotherapy regimen (oxali...
Autores principales: | Zhou, Haitao, Song, Yan, Jiang, Jun, Niu, Haitao, Zhao, Hong, Liang, Jianwei, Su, Hao, Wang, Zheng, Zhou, Zhixiang, Huang, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242454/ https://www.ncbi.nlm.nih.gov/pubmed/28174488 http://dx.doi.org/10.21147/j.issn.1000-9604.2016.06.06 |
Ejemplares similares
-
A pathological complete response after neoadjuvant triplet chemotherapy for locally advanced transverse colon cancer
por: Tominaga, Tetsuro, et al.
Publicado: (2020) -
Triplet versus doublet neoadjuvant chemotherapy regimens for locally advanced gastric cancer: a propensity score matching analysis
por: Chen, Yonghe, et al.
Publicado: (2021) -
Docetaxel, Oxaliplatin and Capecitabine (TEX) triplet regimen as adjuvant chemotherapy in resected gastric adenocarcinoma
por: Thumaty, Divya Bala, et al.
Publicado: (2021) -
A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for
locally advanced gastric cancer
por: Wang, Xiang, et al.
Publicado: (2016) -
Clinical effects of Apatinib combined with DOS neoadjuvant chemotherapy regimen in neoadjuvant chemotherapy for LAGC
por: Zhou, Peng-zhe, et al.
Publicado: (2021)